These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Response to letter: identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose. Biary R, Hoffman RS. Clin Toxicol (Phila); 2013; 51(8):812. PubMed ID: 24053328 [No Abstract] [Full Text] [Related]
3. Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose. Schmidt LE. Clin Toxicol (Phila); 2013 Jul; 51(6):467-72. PubMed ID: 23697458 [Abstract] [Full Text] [Related]
6. [Anaphylactoid reaction in relation to the use of N-acetylcysteine the prevention of paracetamol hepatotoxicity]. Recasens M, Nogué S, Gómez E. Med Clin (Barc); 2001 Nov 03; 117(14):558-9. PubMed ID: 11707227 [No Abstract] [Full Text] [Related]
12. Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Kanter MZ. Am J Health Syst Pharm; 2006 Oct 01; 63(19):1821-7. PubMed ID: 16990628 [Abstract] [Full Text] [Related]
13. Epidemiology, management and outcome of paracetamol poisoning in an inner city emergency department. Carroll R, Benger J, Bramley K, Williams S, Griffin L, Potokar J, Gunnell D. Emerg Med J; 2015 Feb 01; 32(2):155-60. PubMed ID: 24099830 [Abstract] [Full Text] [Related]
14. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Pakravan N, Waring WS, Sharma S, Ludlam C, Megson I, Bateman DN. Clin Toxicol (Phila); 2008 Sep 01; 46(8):697-702. PubMed ID: 18803085 [Abstract] [Full Text] [Related]